Akhondzadeh, Shahin

Bupropion versus methylphenidate in the treatment of children with attention‐deficit/hyperactivity disorder: randomized double‐blind study

Jafarinia, M., Mohammadi, M., Modabbernia, A., Ashrafi, M., Khajavi, D., Tabrizi, M., Yadegari, N., & Akhondzadeh, S. (2012) · Human Psychopharmacology: Clinical and Experimental

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 42

Celecoxib Versus Diclofenac in Mild to Moderate Depression Management Among Breast Cancer Patients: A Double-Blind, Placebo-Controlled, Randomized Trial

Mohammadinejad, P., Arya, P., Esfandbod, M., Kaviani, A., Najafi, M., Kashani, L., Zeinoddini, A., Emami, S. A., & Akhondzadeh, S. (2015) · Annals of Pharmacotherapy

Cancer survivorship and careTreatment of Major Depression

Cited by 39

Acetyl-L-Carnitine as an Adjunctive Therapy in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Placebo-Controlled Trial

Abbasi, S.-H., Heidari, S., Mohammadi, M.-R., Tabrizi, M., Ghaleiha, A., & Akhondzadeh, S. (2011) · Child Psychiatry & Human Development

Attention Deficit Hyperactivity DisorderDevelopmental and Educational Neuropsychology

Cited by 34

Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial

Morabbi, M.-J., Razaghi, E., Moazen-Zadeh, E., Safi-Aghdam, H., Zarrindast, M. R., Vousoghi, N., & Akhondzadeh, S. (2018) · International Clinical Psychopharmacology

Opioid Use Disorder TreatmentSubstance Abuse Treatment and Outcomes

Cited by 32

Agomelatine as a Treatment for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Double-Blind, Randomized Clinical Trial

Salardini, E., Zeinoddini, A., Kohi, A., Mohammadi, M.-R., Mohammadinejad, P., Khiabany, M., Shahriari, M., & Akhondzadeh, S. (2016) · Journal of Child and Adolescent Psychopharmacology

Attention Deficit Hyperactivity DisorderPharmaceutical studies and practices

Cited by 30

Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial

Sahraian, A., Bigdeli, M., Ghanizadeh, A., & Akhondzadeh, S. (2014) · Journal of Affective Disorders

Bipolar Disorder and TreatmentObsessive-Compulsive Spectrum Disorders

Cited by 28